WULF Insider Notice: 52,942 Shares to Be Sold on NASDAQ Sept 19, 2025
Rhea-AI Filing Summary
Terawulf Inc. (WULF) notice reports a proposed sale of 52,942 common shares through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $600,891.70 and an approximate sale date of 09/19/2025. The shares were acquired as a stock award on 06/21/2024 and listed as compensation. The filing also discloses that Catherine Motz sold 21,182 shares on 06/18/2025 for gross proceeds of $82,921.62. The filer affirms they are unaware of any undisclosed material adverse information about the issuer.
Positive
- Proposed sale fully disclosed with broker, share count, aggregate value, and intended sale date
- Acquisition details provided: shares were received as a stock award on 06/21/2024 and recorded as compensation
- Recent prior sale disclosed (21,182 shares on 06/18/2025 for $82,921.62), showing transparency about recent transactions
Negative
- Relationship to issuer not specified in the filing, so investor context about insider status is unclear
- No statement about a 10b5-1 trading plan or other trading instructions is included, leaving context about the timing of the sale unspecified
Insights
TL;DR: Insider plans to sell awarded shares; disclosed recent prior sale; scale appears modest relative to total outstanding shares.
The filing transparently reports a proposed disposition of 52,942 common shares via a registered broker with a stated aggregate market value of $600,891.70 and an intended trade date of 09/19/2025. The shares were obtained as a compensation stock award on 06/21/2024, which is relevant for tax and holding-period considerations. A prior sale of 21,182 shares on 06/18/2025 for $82,921.62 is disclosed, showing recent liquidity activity by the same account. For investors, the disclosures are routine and comply with Rule 144 notice requirements.
TL;DR: Filing meets Rule 144 disclosure elements but provides limited context on relationship to issuer or trading plans.
The notice includes required data points: acquisition date (06/21/2024), nature of acquisition (stock award), payment type (compensation), broker details, and prior sales within three months. The signer affirms absence of undisclosed material adverse information. The document does not state the filer’s relationship to the issuer or whether a 10b5-1 plan governs the proposed sale, leaving procedural context absent. From a compliance standpoint, the form appears complete for Rule 144 notice content provided.